Page 27 - UHN Centre for Mental Health Impact Report 2023
P. 27

RESEARCH




 Leading the Field   Innovative Research



        Unique Lines of Inquiry Explored by UHN Psychiatrists.
 UHN at the Forefront of Psychedelic Research.



 Psychedelic drugs have been held up as   UHN that we secured two of the possible   SUICIDE’S IMPACT
 a potential breakthrough treatment for a   three grants available,” says Dr. Susan
 range of mental illnesses, with their     Abbey, Program Medical Director, Centre   Clinician-Researcher Dr. Zainab Furqan was co-author
 benefits promoted by everyone from     for Mental Health.   of a study that explored the impact of patient suicide
 celebrities to venture capitalists.   on psychiatrists.
 “We are taking the lead in this exciting
 But medical research on their efficacy is   new field with our teams pioneering re-  “We know that losing a patient to suicide has a major
 still in the preliminary stage.   search methodology and advancing pa-  impact on psychiatrists, with many calling it the most
 tient safety protocols.”   significant event of their careers,” says Dr. Furqan.
 UHN researchers are working to remedy
 that and achieved a significant milestone   The research teams aim to investigate the   Research revealed that psychiatrists often experience
 recently by obtaining two $1 million   effects of psilocybin on end-of-life care for   guilt and self-doubt after such an event, compromising
 grants from the Canadian Institutes of   patients with advanced cancer (led by Drs.   their ability to assess suicide risk. Up to 80% of psych-
 Health Research (CIHR).   Sarah Hales, Emma Hapke and Daniel   iatrists will have a patient die by suicide at some point
 Rosenbaum) and treatment-resistant   in their career, but many receive no training on how
 These grants were part of a special     depression (led by Dr. Joshua Rosenblat),   to cope. The authors’ recommend urgent changes,
 competition to study the therapeutic     contributing to the advancement of   including pre-emptive training that identifies practical
 potential of psilocybin (the active   patient safety protocols and research   strategies for supporting colleagues and grieving
 compound in “magic mushrooms”) in     methodology in this emerging field.   families after a patient suicide.  > learn more
 combination with psychotherapy.
 Clinical trials are scheduled to commence
 “It’s a testimony to the quality of work at   in early 2024.
        HEALTH AND HUMANITIES

 Drs. Sarah Hales and Joshua Rosenblat
        Dr. Suze Berkhout, a Clinician-Investigator, co-leads
        The Frictions of Futurity in Transplant Medicine Project,
        which brings together the diverse perspectives of
        artists, researchers, academics, healthcare providers,
        transplant recipients and their support persons.


        “Participants not only create, but deconstruct and
        challenge knowledge surrounding transplantation
        through their artistic practice,” says Dr. Berkhout.


        Year-round events showcase digital stories created by
        long-term transplant recipients, providing a deeper
        understanding of the transplantation experience.
        Conversations address topics such as quality of life
        pre- and post- transplantation and justice concerns
        related to organ failure, long waitlists and supply-
        demand issues.
                                                                                                                27
 26                                                                                                             27
   22   23   24   25   26   27   28   29   30